1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 113 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valveAli, O.; Chapman, M.; Thanh, H.; Chirkov, Y.; Heresztyn, T.; Mundisugih, J.; Horowitz, J.
2018Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudyHorowitz, J.; De Caterina, R.; Heresztyn, T.; Alexander, J.; Andersson, U.; Lopes, R.; Steg, P.; Hylek, E.; Mohan, P.; Hanna, M.; Jansky, P.; Granger, C.; Wallentin, L.
2014High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialHijazi, Z.; Siegbahn, A.; Andersson, U.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Mohan, P.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
2013Navigating the fine line between benefit and risk in chronic atrial fibrillation: rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)Carrington, M.; Ball, J.; Horowitz, J.; Marwick, T.; Mahadevan, G.; Wong, C.; Abhayaratna, W.; Haluska, B.; Thompson, D.; Scuffham, P.; Stewart, S.
2014Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathySingh, K.; Carson, K.; Usmani, Z.; Sawhney, G.; Shah, R.; Horowitz, J.
2014Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathySingh, K.; Carson, K.; Shah, R.; Sawhney, G.; Singh, B.; Parsaik, A.; Gilutz, H.; Usmani, Z.; Horowitz, J.
2015Impaired platelet nitric oxide response in patients with new onset atrial fibrillationProcter, N.; Ball, J.; Liu, S.; Hurst, N.; Nooney, V.; Goh, V.; Stafford, I.; Heresztyn, T.; Carrington, M.; Ngo, D.; Hylek, E.; Isenberg, J.; Chirkov, Y.; Stewart, S.; Horowitz, J.
2014Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialWallentin, L.; Hijazi, Z.; Andersson, U.; Alexander, J.; De Caterina, R.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; Åsberg, S.; Granger, C.; Siegbahn, A.
2016Can perhexiline be utilized without long-term toxicity? A clinical practice auditPhuong, H.; Choi, B.; Chong, C.; Raman, B.; Horowitz, J.
2016History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDe Caterina, R.; Andersson, U.; Alexander, J.; Al-Khatib, S.; Bahit, M.; Goto, S.; Hanna, M.; Held, C.; Hohnloser, S.; Hylek, E.; Lanas, F.; Lopes, R.; López-Sendón, J.; Renda, G.; Horowitz, J.; Granger, C.; Wallentin, L.

Discover